<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05126264</url>
  </required_header>
  <id_info>
    <org_study_id>2019-000736-25</org_study_id>
    <nct_id>NCT05126264</nct_id>
  </id_info>
  <brief_title>Efficacy of Chronoterapy in Oral Surgery</brief_title>
  <acronym>ECOS</acronym>
  <official_title>Efficacy of the Dosage of a Non-steroidal Anti-inflammatory (Ibuprofen) on Inflammation and Postoperative Pain After Lower Third Molar Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Complutense de Madrid</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Complutense de Madrid</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lower third molar extraction is one of the most common treatments in oral surgery practice.&#xD;
      It is a treatment with inherent complications such as postoperative pain, swelling or&#xD;
      trismus. In order to minimize disconfort after extraction, analgesic and anti-inflammatory&#xD;
      medication is prescribed. Recently, it is seen that circadian rhythm may play an important&#xD;
      role on drugs metabolism, modulating its effect depending on the moment of administration.&#xD;
      The aim of the study is to analyze if dosage modification of a Non Steroideal&#xD;
      Anti-Inflammatory (ibuprofen) affects on postoperative pain, swelling and open mouth&#xD;
      limitation comparing to the normal dosage.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized crossover split-mouth clinical trial will be performed. After third molar&#xD;
      extractions, patients will be prescribed ramdomly in one side wit the normal medication&#xD;
      dosage while the contralateral side will be prescribed a modified dosage. Moreover, a blood&#xD;
      sample will be obtained to analize the inflammatory profile.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 10, 2021</start_date>
  <completion_date type="Anticipated">December 20, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 10, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Split-mouth design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative Pain</measure>
    <time_frame>From the day of the surgical procedure to the seventh-day</time_frame>
    <description>Postoperative pain with visual analogue scale (VAS) from 0 (no pain) to 10 (maximum pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Swelling</measure>
    <time_frame>Baseline and post operatory (day 1, day 3, day 7)</time_frame>
    <description>Distance from tragus to pogonion in milimiters</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Trismus</measure>
    <time_frame>Baseline and post operatory (day 1, day 3 and day 7)</time_frame>
    <description>Open mouth limitation in milimiters. Interincisal distance</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Tooth, Impacted</condition>
  <condition>Trismus</condition>
  <condition>Pain</condition>
  <condition>Inflammatory Response</condition>
  <arm_group>
    <arm_group_label>Modified dosage</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ibuprofen pill at morning and afternoon; Placebo at night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal dosage</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ibuprofen three times a day: morning, afternoon and night</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 400 mg</intervention_name>
    <description>morning and afternoon</description>
    <arm_group_label>Modified dosage</arm_group_label>
    <other_name>Modified dosage</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen 400 mg</intervention_name>
    <description>morning, afternoon and night</description>
    <arm_group_label>Normal dosage</arm_group_label>
    <other_name>Conventional dosage</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 35 years old&#xD;
&#xD;
          -  Bilateral retained lower third molar&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  NSAID allergic&#xD;
&#xD;
          -  Contraindication for surgical removal of third molar&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Fabian Perez-Gonzalez, DDM, MS</last_name>
    <phone>0034670716375</phone>
    <email>fabianpe@ucm.es</email>
  </overall_contact>
  <reference>
    <citation>Gutiérrez-Corrales A, Campano-Cuevas E, Castillo-Dalí G, Serrera-Figallo MÁ, Torres-Lagares D, Gutiérrez-Pérez JL. Relationship between salivary biomarkers and postoperative swelling after the extraction of impacted lower third molars. Int J Oral Maxillofac Surg. 2017 Feb;46(2):243-249. doi: 10.1016/j.ijom.2016.10.005. Epub 2016 Nov 3.</citation>
    <PMID>27816275</PMID>
  </reference>
  <reference>
    <citation>Albuquerque AFM, Fonteles CSR, do Val DR, Chaves HV, Bezerra MM, Pereira KMA, de Barros Silva PG, de Lima BB, Soares ECS, Ribeiro TR, Costa FWG. Effect of pre-emptive analgesia on clinical parameters and tissue levels of TNF-α and IL-1β in third molar surgery: a triple-blind, randomized, placebo-controlled study. Int J Oral Maxillofac Surg. 2017 Dec;46(12):1615-1625. doi: 10.1016/j.ijom.2017.05.007. Epub 2017 Jun 10.</citation>
    <PMID>28610818</PMID>
  </reference>
  <reference>
    <citation>Keller M, Mazuch J, Abraham U, Eom GD, Herzog ED, Volk HD, Kramer A, Maier B. A circadian clock in macrophages controls inflammatory immune responses. Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21407-12. doi: 10.1073/pnas.0906361106. Epub 2009 Dec 1.</citation>
    <PMID>19955445</PMID>
  </reference>
  <reference>
    <citation>Curtis AM, Fagundes CT, Yang G, Palsson-McDermott EM, Wochal P, McGettrick AF, Foley NH, Early JO, Chen L, Zhang H, Xue C, Geiger SS, Hokamp K, Reilly MP, Coogan AN, Vigorito E, FitzGerald GA, O'Neill LA. Circadian control of innate immunity in macrophages by miR-155 targeting Bmal1. Proc Natl Acad Sci U S A. 2015 Jun 9;112(23):7231-6. doi: 10.1073/pnas.1501327112. Epub 2015 May 20.</citation>
    <PMID>25995365</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2021</study_first_submitted>
  <study_first_submitted_qc>November 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Complutense de Madrid</investigator_affiliation>
    <investigator_full_name>Jesús Torres García Denche</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Third molar</keyword>
  <keyword>Chronotherapy</keyword>
  <keyword>Ibuprofen</keyword>
  <keyword>Randomized</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tooth, Impacted</mesh_term>
    <mesh_term>Trismus</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ibuprofen</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

